Inquire About a Product| Product: | Levetiracetam-d6 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | D14288 | ||||||||
| Unlabeled CAS Number: | 102767-28-2 | ||||||||
| CAS Number: | 1133229-30-7 | ||||||||
| Synonyms: |
(αS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide; 2(S)-(2-Oxopyrrolidin-1-yl)butyramide |
||||||||
| Pricing: |
|
||||||||
| Formula: | C8H8N2O2D6 | ||||||||
| Enrichment: | 99.4% D | ||||||||
| Chemical Purity: | 99.4% | ||||||||
| Molecular Weight: | 176.25 | ||||||||
| Structure: |
|
||||||||
| Appearance: | Solid | ||||||||
| Category: | Labeled Reference Standards | ||||||||
| Stability: | Stable under recommended storage conditions. | ||||||||
| Storage: |
Keep container tightly closed in a dry and well-ventilated place |
||||||||
| Transportation: |
Non-hazardous for transport |
||||||||
| Literature References: |
The Use of Drug Metabolism for Prediction of Intestinal Permeability: Mei-Ling Chen and Lawrence Yu; Author Affliations: Office of Pharmaceutical Science, Center for Drug Evaluation and Research, Food and Drug Administration, and Office of Generic Drugs, Office of Pharmaceutical Science, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993 |
||||||||
| MSDS: | |||||||||
| Description: | The labelled (S)-enantiomer of the ethyl analog of Piracetam. | ||||||||
| Applications: | Used as an anticonvulsant. |